Search / Trial NCT06617442

Esophageal Safety of High and Very High Power Short Duration Pulmonary Vein Isolation: a Randomized Comparison of the 50W and 90W Power Settings

Launched by SEMMELWEIS UNIVERSITY · Sep 25, 2024

Trial Information

Current as of October 08, 2024

Completed

Keywords

Pulmonary Vein Isolation Pvi Hpsd High Power Short Duration Esophageal Injury

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Patients with paroxysmal or persistent atrial fibrillation undergoing their first pulmonary vein isolation procedure
  • Exclusion Criteria:
  • * Additional ablation performed outside PVI
  • * Contraindications to postoperative upper endoscopy

About Semmelweis University

Semmelweis University, located in Budapest, Hungary, is a prestigious institution renowned for its commitment to advancing medical education, research, and healthcare innovation. As a prominent clinical trial sponsor, the university leverages its extensive expertise in various medical fields to conduct rigorous clinical studies aimed at improving patient outcomes and enhancing therapeutic strategies. With a focus on ethical standards and scientific excellence, Semmelweis University collaborates with a network of healthcare professionals and researchers to translate groundbreaking discoveries into practical applications, ultimately contributing to the global advancement of medical science.

Locations

Budapest, , Hungary

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0